文献

J-GLOBAL ID：201702212984179238   整理番号：17A0790957

6か月の生物学的DMARD治療で機能的寛解を達成したリウマチ性関節炎患者の臨床的特徴

Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment

著者 (14件)： Miwa Yusuke (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Takahashi Ryo (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Ikari Yuzo (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Maeoka Airi (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Nishimi Shinichiro (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Oguro Nao (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Hayashi Tomoki (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Hatano Mika (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Isojima Sakiko (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Yanai Ryo (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Kasama Tsuyoshi (Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan) ,  Toyoshima Yoichi (Department of Orthopedics, Showa University School of Medicine, Japan) ,  Inagaki Katsunori (Department of Orthopedics, Showa University School of Medicine, Japan) ,  Sanada Kenji (Department of Psychiatry, Showa University School of Medicine, Japan)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 56  号： 8  ページ： 903-906(J-STAGE)  発行年： 2017年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 目的:これまでの研究で機能的寛解の予後因子が報告されているが...

シソーラス用語： ヒト ,...
準シソーラス用語： *DMARD ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0790957&from=J-GLOBAL&jstjournalNo=U0033A") }}

著者キーワード (4件)： rheumatoid arthritis ,  health assessment questionnaire disability index (HAQ-DI) ,  quality of life (QOL) ,  functional remission

分類 (1件)： 免疫性疾患・アレルギー性疾患の治療  (GD04030Y)

物質索引 (1件)： メトトレキサート

引用文献 (15件)：

• 1. Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 68: 1-26, 2016.
• 2. Haugeberg G, Boyesen P, Helgetveit K, Proven A. Clinical and radiographic outcomes in patients diagnosed with early rheumatoid arthritis in the first years of the biologic treatment era: a 10-year prospective observational study. J Rheumatol 42: 2279-2287, 2015.
• 3. Izumi K, Kaneko Y, Yasuoka H, et al. Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52. Mod Rheumatol 25: 31-37, 2015.
• 4. Kojima M, Kojima T, Suzuki S, et al. Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis. Int J Rheum Dis 2015 (Epub ahead of print).
• 5. Odai T, Matsunawa M, Takahashi R, et al. Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 36: 1158-1165, 2009.

タイトルに関連する用語 (6件)： 生物学的DMARD ,  治療 ,  寛解 ,  リウマチ性関節炎 ,  患者 ,  臨床的特徴